Filing Details

Accession Number:
0001437749-22-028439
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-12-05 17:30:12
Reporting Period:
2022-11-21
Accepted Time:
2022-12-05 17:30:12
Original Submission Date:
2022-11-23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389545 Novabay Pharmaceuticals Inc. NBY Pharmaceutical Preparations (2834) 680454536
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1738781 Audrey Kunin C/O Novabay Pharmaceuticals, Inc.
2000 Powell Street, Suite 1150
Emeryville CA 94608
Chief Product Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-21 5,960 $2.10 1 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.
  2. This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction.
  4. By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.